| 51 | SOLVSolventum Corp |
8,3 mld USD |
18,7% |
2025 |
| 52 | ICLRIcon PLC |
8,3 mld USD |
2,8% |
2025 |
| 53 | ZBHZimmer Biomet Holdings, Inc. |
8,2 mld USD |
8,6% |
2025 |
| 54 | ARDTArdent Health, Inc. |
6,3 mld USD |
2,1% |
2025 |
| 55 | OGNOrganon & Co. |
6,2 mld USD |
3,0% |
2025 |
| 56 | SNNSmith & Nephew PLC |
6,2 mld USD |
10,1% |
2025 |
| 57 | EWEdwards Lifesciences Corp |
6,1 mld USD |
17,7% |
2025 |
| 58 | STESTERIS plc |
5,9 mld USD |
13,2% |
2026 |
| 59 | EHCEncompass Health Corp |
5,9 mld USD |
9,5% |
2025 |
| 60 | AGLagilon health, inc. |
5,9 mld USD |
-6,6% |
2025 |
| 61 | RMDResmed Inc |
5,7 mld USD |
26,9% |
2026 |
| 62 | OPCHOption Care Health, Inc. |
5,6 mld USD |
3,7% |
2025 |
| 63 | ONCBeOne Medicines Ltd. |
5,3 mld USD |
5,4% |
2025 |
| 64 | PACSPACS Group, Inc. |
5,3 mld USD |
3,6% |
2025 |
| 65 | INCYIncyte Corp |
5,1 mld USD |
25,0% |
2025 |
| 66 | BLCOBausch & Lomb Corp |
5,1 mld USD |
-7,1% |
2025 |
| 67 | ENSGEnsign Group, Inc |
5,1 mld USD |
6,8% |
2025 |
| 68 | HLFHerbalife Ltd. |
5 mld USD |
4,5% |
2025 |
| 69 | ELANElanco Animal Health Inc |
4,7 mld USD |
-4,9% |
2025 |
| 70 | DXCMDexcom Inc |
4,7 mld USD |
17,9% |
2025 |
| 71 | ILMNIllumina, Inc. |
4,3 mld USD |
19,6% |
2025 |
| 72 | IDXXIdexx Laboratories Inc |
4,3 mld USD |
24,6% |
2025 |
| 73 | JAZZJazz Pharmaceuticals plc |
4,3 mld USD |
-8,3% |
2025 |
| 74 | PRGOPERRIGO Co plc |
4,3 mld USD |
-33,5% |
2025 |
| 75 | COOCooper Companies, Inc. |
4,1 mld USD |
9,2% |
2025 |
| 76 | ALGNAlign Technology Inc |
4 mld USD |
10,2% |
2025 |
| 77 | CRLCharles River Laboratories International, Inc. |
4 mld USD |
-3,6% |
2025 |
| 78 | ALHCAlignment Healthcare, Inc. |
3,9 mld USD |
-0,0% |
2025 |
| 79 | RDYDR Reddys Laboratories Ltd |
3,8 mld USD |
17,4% |
2025 |
| 80 | GMABGenmab A/S |
3,7 mld USD |
25,9% |
2025 |
| 81 | ALNYAlnylam Pharmaceuticals, Inc. |
3,7 mld USD |
8,4% |
2025 |
| 82 | XRAYDENTSPLY SIRONA Inc. |
3,7 mld USD |
-16,3% |
2025 |
| 83 | ACHCAcadia Healthcare Company, Inc. |
3,3 mld USD |
-33,3% |
2025 |
| 84 | SGRYSurgery Partners, Inc. |
3,3 mld USD |
-2,4% |
2025 |
| 85 | AHCOAdaptHealth Corp. |
3,2 mld USD |
-2,2% |
2025 |
| 86 | BMRNBiomarin Pharmaceutical Inc |
3,2 mld USD |
10,8% |
2025 |
| 87 | BKDBrookdale Senior Living Inc. |
3,2 mld USD |
-8,2% |
2025 |
| 88 | UTHRUNITED THERAPEUTICS Corp |
3,2 mld USD |
41,9% |
2025 |
| 89 | MMEDMiniMed Group, Inc. |
3,1 mld USD |
-10,7% |
2026 |
| 90 | WSTWest Pharmaceutical Services Inc |
3,1 mld USD |
16,1% |
2025 |
| 91 | ULSUL Solutions Inc. |
3,1 mld USD |
10,6% |
2025 |
| 92 | AMRXAmneal Pharmaceuticals, Inc. |
3 mld USD |
2,4% |
2025 |
| 93 | GMEDGlobus Medical Inc |
2,9 mld USD |
18,3% |
2025 |
| 94 | NBIXNeurocrine Biosciences Inc |
2,9 mld USD |
16,7% |
2025 |
| 95 | ACHAccendra Health Inc |
2,8 mld USD |
-39,8% |
2025 |
| 96 | QDELQuidelOrtho Corp |
2,7 mld USD |
-41,5% |
2025 |
| 97 | FTREFortrea Holdings Inc. |
2,7 mld USD |
-36,2% |
2025 |
| 98 | NVSTEnvista Holdings Corp |
2,7 mld USD |
1,7% |
2025 |
| 99 | PODDInsulet Corp |
2,7 mld USD |
9,1% |
2025 |
| 100 | MEDPMedpace Holdings, Inc. |
2,5 mld USD |
17,8% |
2025 |